{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260604006839/en/AN2-Therapeutics-Reports-Positive-Enabling-Data-Supporting-Advancement-of-Oral-AN2-502998-to-Phase-2-Study-for-Chronic-Chagas-Disease", "message": "News view counter 780369 successfully enlarged"}